TISMET Trademark
Serial Number: 79363014 • Registration: 7273197
TISMET is a trademark filed by
Kairos Medical AG
on December 20, 2022. The trademark is classified under Class 6 (Metal Goods), Class 10 (Medical Apparatus).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Melissa A. Nowak Christensen O'Connor Johnson Kindness
1201 Third Avenue
Suite 3600
Seattle
WA 98101-3029
Trademark Details
Filing Date
December 20, 2022
Registration Date
January 16, 2024
Published for Opposition
October 31, 2023
Filing History
NOTIFICATION PROCESSED BY IB
Mar 11, 2024 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Feb 21, 2024 FICS
FINAL DISPOSITION PROCESSED
Feb 21, 2024 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 15, 2024 GPAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 22, 2024 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 16, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 16, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Nov 1, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 31, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 31, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 11, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 11, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 11, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 21, 2023 CNSA
ASSIGNED TO EXAMINER
Sep 21, 2023 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 13, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 13, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 13, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 13, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 13, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 13, 2023 COAR
APPLICATION FILING RECEIPT MAILED
Feb 28, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 22, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 16, 2023 REPR
